发明名称 Alpha-MSH therapies for treatment of autoimmune disease
摘要 Methods and compositions for the enteral treatment of autoimmune disease such a multiple sclerosis with polypeptide therapeutics. Enteral therapeutics comprise monomeric alpha-MSH polypeptides such as ACTH. Therapeutic formulations of the invention may be used to reduce the incidence or severity of autoimmune disease. For instance methods for the oral treatment of multiple sclerosis with alpha-MSH and ACTH are described.
申请公布号 US8758770(B2) 申请公布日期 2014.06.24
申请号 US201012897591 申请日期 2010.10.04
申请人 Research Development Foundation 发明人 Brod Staley A.
分类号 A61K38/22;C07K14/575;C07K14/47 主分类号 A61K38/22
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A method for treating or delaying the onset of a T cell mediated inflammatory autoimmune disease in a human subject comprising orally administering to the subject an effective dose of ACTH (adrenocorticotropic hormone).
地址 Carson City NV US